France's coronavirus death toll passes 23,000 [Reuters]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Reuters
France's coronavirus death toll passes 23,000 PARIS (Reuters) - France became the fourth country to report more than 23,000 coronavirus-linked fatalities on Monday, while the number of new confirmed cases rose at its sharpest pace in almost two weeks. The latest figures from the Health Ministry come a day before Prime Minister Edouard Philippe is due to present to parliament the government’s plan to unwind national lockdown that has been in place since March 17 and is due to expire on May 11. The number of people in hospital with COVID-19 - the lung disease caused by the new coronavirus - fell for the 13th day running to 28,055, while the number of people in intensive care decreased for the 19th consecutive time to 4,608. But the number of deaths rose by 437 to 23,293, its sharpest rate of increase in four days. And the total number of confirmed cases was up 3,764, at 128,339. This 3% increase was the highest since April 14. The number of probable cases in nursing homes was more or le
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $850.00 to $1,057.00. They now have a "buy" rating on the stock.MarketBeat
- Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target raised by analysts at BMO Capital Markets from $725.00 to $850.00. They now have an "outperform" rating on the stock.MarketBeat
- Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $767.00 price target on the stock.MarketBeat
- Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)GlobeNewswire
REGN
Earnings
- 10/28/25 - Beat
REGN
Sec Filings
- 11/28/25 - Form 144
- 11/24/25 - Form 4
- 11/24/25 - Form 4
- REGN's page on the SEC website